Coagulopathy

AUG 20, 2026 · PHASE 1 TRIAL

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

ClinicalTrials.gov

First-in-patient Phase 1 safety and dose-finding study with no results posted; designed to establish safety and tolerability of BAY 3389934 in sepsis-induced coagulopathy.

AUG 20, 2026 · PHASE 2 TRIAL

Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy

ClinicalTrials.gov

This is a study registration with no results posted; the trial is not yet recruiting and has not been conducted, making it a planning document describing a future phase IIb study.